Log In
Print
BCIQ
Print
Print this Print this
 

rhLCAT (ACP-501, MEDI6012)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionRecombinant human lecithin-cholesterol acyltransferase (LCAT)
Molecular Target Cholesterol
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today